Top diabetes experts takes part in exciting DT live interview
A top consultant in endocrinology has spoken about how a ‘slightly inebriated’ anaesthetist inspired him to become integrally involved in diabetes inpatient guidelines.
Professor Ketan Dhatariya, a Consultant in Diabetes and Endocrinology at the Norfolk and Norwich University Hospitals NHS Foundation Trust, took part in the very first online Big Interview for The Diabetes Times.
He was interviewed by Editor Oliver Jelley who asked Professor Dhatariya how he became involved in writing inpatient guidelines.
Professor Dhatariya, who is currently the Chair of the Joint British Diabetes Societies Inpatient Care Group, explained how an encounter with a colleague at a social function marked the start of his interest.
He said: “I think it really came about from the work I did on intensive care. When I was first appointed in Norwich I was at a social event with an anaesthetist who progressively got slowly more and more inebriated. He came up to me and put his finger in my chest pointing ‘why do diabetes doctors insist on using normal saline in diabetic ketoacidosis (DKA)?’
“Well, it got me thinking and I went away afterwards and I did a little work on why.”
This led to Professor Dhatariya publishing an editorial in the BMJ on the subject of saline and DKA, which attracted the attention of one of the lead authors on the DKA guidelines which were due to be published.
“From there, I realised that there are very few people who are interested in inpatient diabetes. There are very few studies into inpatient diabetes and most of them are done in the US, because the big companies aren’t interested in inpatients. It’s just too small for them.
“But for the person with diabetes who is in the inpatient system, it’s a huge, huge burden.”
Since then Professor Dhatariya, who has been in the medical profession for more than 30 years, has contributed to hundreds of research papers predominantly in his areas of interest, including inpatient diabetes, peri-operative diabetes care, the management of diabetes-related emergencies and the diabetic foot.
He said: “The success of guidance that’s come out is because we asked the diabetes community ‘what is it that you want us to write guidance on?’.”
Just this week JBDS-IP has published the first ever guidelines on diabetes and cancer.
Professor Dhatariya added: “It’s all about minimising the variation in care, and it’s written on consensus, because there’s not much evidence and they’ve been widely accepted, accepted and adapted.”
Professor Dhatariya is also Chair of the Examining Board for the UK Specialist Clinical Exam in Diabetes and Endocrinology, as well as Chair of the newly developed European Board Examination in Endocrinology, Diabetes and Metabolism.
He is the President of the Diabetes and Endocrine section of the Royal Society of Medicine. He is an Associate Editor of Diabetic Medicine and BMJ Open Diabetes Research & Care.
To watch the interview, click here.